SIRT3 and Alzheimer disease: The prevention of SIRT3 reduction by PL171 attenuated Aβ42O-induced neuronal defects, which were abolished by the SIRT3 inhibitor, suggesting that SIRT3 could be a therapeutic target for AD treatment.